NCT03712878View on ClinicalTrials.gov

2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 19, 2018

Primary Completion Date

March 19, 2025

Study Completion Date

March 19, 2025

Conditions
Hematopoietic and Lymphoid Cell Neoplasm
Interventions
RADIATION

Total-Body Irradiation

Undergo TBI

PROCEDURE

Donor Lymphocyte Infusion

Given IV

DRUG

Cyclophosphamide

Given IV

PROCEDURE

Allogeneic Hematopoietic Stem Cell Transplantation

Undergo HSCT

DRUG

Tacrolimus

Given IV

DRUG

Mycophenolate Mofetil

Given IV

Trial Locations (1)

19107

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT03712878 - 2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies | Biotech Hunter | Biotech Hunter